^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    177Lu-DOTA-girentuximab (TLX250)

    i
    Other names: TLX250, Lu-177-DOTA-cG250
    Associations
    News
    Trials
    Company:
    Telix
    Drug class:
    Ionizing radiation emitter, Carbonic anhydrase IX inhibitor
    Related drugs:
    Associations
    News
    Trials